You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - FRIDAY, JANUARY 4TH, 2019
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 23454.23 768.01 (3.39%) | NASDAQ 6738.02 274.52 (4.25%) | S&P 500 2526.29 78.4 (3.20%)
|
Time of Screening :
1/4/2019 12:53:17 PM Report Released :
1/4/2019 1:07:02 PM
Price is:
Above 52W High and Less Than 52W High
but within 15% of the 52 Week High
Volume Is:
At least 57.5% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
PLNT
- NYSE
Planet Fitness Inc
|
$55.03
|
+2.23
4.22%
|
$55.36
|
1,018,196
81.85% of 50 DAV
50 DAV is 1,244,000
|
$58.50
-5.93%
|
11/7/2018 |
$57.10
|
PP = $55.45
MB = $58.22 |
Most Recent Note - 1/4/2019 1:04:23 PM
Y - Consolidating above its 50 DMA line ($52.23) after finding prompt support last week. It faces little resistance due to overhead supply up to the $58.50 level. The recent low ($48.00) and its 200 DMA line ($47.06) define the important near-term support.
>>> The latest Featured Stock Update with an annotated graph appeared on 12/14/2018. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
AON
- NYSE - INSURANCE - Insurance Brokers
Aon Plc
|
$143.91 |
+2.03
1.43%
|
$144.69
|
$166.55
|
-13.59% |
669,465
60.69%
|
1,103,000
|
Most Recent Note for AON - 1/4/2019 12:54:09 PM
Slumped below its 200 DMA line with a streak of losses. Recent quarterly earnings increases have been above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history remains a concern.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AUDC
- NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Audiocodes Ltd
|
$11.51 |
+0.72
6.67%
|
$11.59
|
$12.96
|
-11.19% |
179,963
83.32%
|
216,000
|
Most Recent Note for AUDC - 1/4/2019 12:56:27 PM
This Israel-based Telecom firm found support at its 200 DMA line and is rebounding above its 50 DMA line. Last noted in the 11/12/18 mid-day report - "Reported earnings +90% on +14% sales revenues for the Sep '18 quarter, its 7th consecutive quarterly comparison above the +25% minimum guideline (C criteria). Sales revenues growth rate improved in recent quarters, an encouraging sign."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BSTC
- NASDAQ - Medical-Biomed/Biotech
Biospecifics Technologie
|
$61.12 |
+0.96
1.60%
|
$62.60
|
$66.21
|
-7.69% |
30,464
80.17%
|
38,000
|
Most Recent Note for BSTC - 1/4/2019 12:57:51 PM
Thinly traded Biomed/Biotech firm is consolidating above its 50 DMA line and perched near its 52-week high. Earnings increases have been above the +25% minimum guideline (C criteria) in the 4 latest quarterly comparisons through Sep '18. Sales revenues growth showed acceleration, but quarterly totals have been in the $7-8 million range, still rather minuscule in the context of all publicly traded companies.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
KL
- NYSE - Mining-Gold/Silver/Gems
Kirkland Lake Gold Ltd
|
$25.84 |
-0.90
-3.37%
|
$26.36
|
$26.79
|
-3.55% |
835,554
71.17%
|
1,174,000
|
Most Recent Note for KL - 1/4/2019 12:58:28 PM
Hit another new 52-week high on the prior session. Stubbornly held its ground following an impressive streak of gains. Reported strong earnings increases with strong sales revenues growth in the Jun and Sep '18 quarterly comparisons. Prior mid-day reports noted - "Limited history is a concern, however quarterly comparisons through Mar '18 have shown strong increases in earnings versus the year ago periods for this Canada-based Mining - Gold/Silver/Gems firm."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MKTX
- NASDAQ - FINANCIAL SERVICES - Investment Brokerage - Nationa
Marketaxess Holdings Inc
|
$213.05 |
+5.29
2.55%
|
$214.37
|
$231.33
|
-7.90% |
198,124
78.00%
|
254,000
|
Most Recent Note for MKTX - 1/4/2019 1:00:05 PM
Abruptly retreated from its all-time high since last noted with caution in the 12/11/18 mid-day report - "Reported earnings +18% on +6% sales revenues for the Sep '18 quarter. Prior quarterly comparisons were also below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been strong."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PCSB
- NASDAQ - Banks-Northeast
P C S B Financial Corp
|
$20.02 |
+0.20
1.01%
|
$20.13
|
$22.34
|
-10.38% |
72,587
172.83%
|
42,000
|
Most Recent Note for PCSB - 1/4/2019 1:01:41 PM
Today's 7th consecutive gain has it rebounding near its 200 DMA line ($20.05) which acted as resistance in recent weeks. Reported earnings +40% on +10% sales revenues for the Sep '18 quarter. Noted in prior mid-day reports - "Limited history is a concern for this small NY-based Bank holding company."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PLAB
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
Photronics Inc
|
$9.68 |
+0.21
2.16%
|
$9.75
|
$11.00
|
-12.05% |
299,549
59.43%
|
504,000
|
Most Recent Note for PLAB - 1/4/2019 1:02:02 PM
Prior mid-day reports repeatedly noted - "Overhead supply up to the $13 level remains to act as resistance. Recent quarters through Oct '18 showed improving sales and great earnings increases well above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) has been erratic and below guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
REGN
- NASDAQ - DRUGS - Biotechnology
Regeneron Pharmaceutical
|
$397.46 |
+25.38
6.82%
|
$399.20
|
$416.49
|
-4.57% |
524,189
65.20%
|
804,000
|
Most Recent Note for REGN - 1/4/2019 1:05:16 PM
Challenging prior highs with today's big gain. Faces additional overhead supply to act as resistance. Reported earnings +47% on +11% sales revenues for the Sep '18 quarter, its 6th consecutive quarter above the +25% minimum guideline (C criteria). Downturn in FY '15 earnings was a flaw in its annual earnings (A criteria) history.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SKM
- NYSE - TELECOMMUNICATIONS - Telecom Services - Foreign
S K Telecom Co Ltd Ads
|
$27.57 |
+0.78
2.91%
|
$27.60
|
$28.97
|
-4.83% |
430,108
64.68%
|
665,000
|
Most Recent Note for SKM - 1/4/2019 1:06:29 PM
Still perched within striking distance of its 52-week high after finding support near its 50 DMA line in recent weeks. Fundamental concerns remain. This South Korean Telecom Services firm was noted with caution in prior mid-day reports - "Quarterly and annual earnings (C and A criteria) history is not a match with the investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TMO
- NYSE - CONGLOMERATES - Conglomerates
Thermo Fisher Scientific
|
$223.42 |
+11.25
5.30%
|
$223.72
|
$253.91
|
-12.01% |
1,227,483
63.08%
|
1,946,000
|
Most Recent Note for TMO - 1/4/2019 1:06:55 PM
Reported earnings +13% on +16% sales revenues for the Sep '18 quarter. recently slumped below its 200 DMA line ($224) and prior low which acted as support in prior months. Noted with caution in prior mid-day reports - "Reported earnings +20% on +22% sales revenues for the Jun '18 quarter. Quarterly comparisons had earnings growth below the +25% minimum guideline (C criteria). Sales and earnings history are below guidelines of the fact-based investment system."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
